| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(05)79055-3 |
| P698 | PubMed publication ID | 9643800 |
| P2093 | author name string | C K Yeung | |
| Y M Lo | |||
| C C Pang | |||
| K L Tong | |||
| N M Hjelm | |||
| M S Tein | |||
| P2860 | cites work | Cell migration, chimerism, and graft acceptance | Q34178622 |
| Microsatellite alterations in plasma DNA of small cell lung cancer patients. | Q34394739 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Plasma DNA as cell death marker in elderly patients | Q72617178 | ||
| Microchimerism and graft tolerance: cause or effect? | Q73336353 | ||
| P433 | issue | 9112 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1329-1330 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients | |
| P478 | volume | 351 |
| Q92531690 | A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant |
| Q37370920 | A novel noninvasive method to detect rejection after heart transplantation |
| Q38966041 | Advances in diagnostics for transplant rejection |
| Q91554346 | Analysis of fragment size distribution of cell-free DNA: A potential non-invasive marker to monitor graft damage in living-related liver transplantation for inborn errors of metabolism |
| Q91883185 | Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients |
| Q61455724 | Application of graft-derived cell-free DNA in ornithine transcarbamylase deficiency patient after living donor liver transplantation: Two case reports |
| Q54337731 | Association of donor-specific microchimerism with graft dysfunction in kidney transplant patients. |
| Q39384930 | Biomarkers to detect rejection after kidney transplantation. |
| Q45971335 | Cell-Free DNA and Active Rejection in Kidney Allografts. |
| Q49992541 | Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases |
| Q37209930 | Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation |
| Q89203907 | Circulating cell-free DNA as a biomarker of tissue injury: Assessment in a cardiac xenotransplantation model |
| Q35078413 | Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. |
| Q90061864 | Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation |
| Q93063128 | Detecting Graft-Derived Cell-Free DNA Through Amplification Refractory Mutation System Polymerase Chain Reaction in Living-Donor Liver Transplantation: Report of 2 Cases |
| Q90411116 | Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study |
| Q40326468 | Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation |
| Q91873353 | Early changes in cell-free DNA levels in newly transplanted heart transplant patients |
| Q33245160 | Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments |
| Q34224506 | Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury |
| Q61799424 | Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy |
| Q33559093 | Evaluation of Digital PCR as a Technique for Monitoring Acute Rejection in Kidney Transplantation |
| Q26863327 | Free DNA--new potential analyte in clinical laboratory diagnostics? |
| Q40228674 | Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study |
| Q41705419 | Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid. |
| Q36986986 | MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. |
| Q34663271 | Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor |
| Q46106628 | Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant Monitoring |
| Q91705730 | Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation |
| Q60916304 | Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies |
| Q104748205 | Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection |
| Q36238500 | Noninvasive monitoring of infection and rejection after lung transplantation |
| Q34503698 | Novel diagnostics in renal transplantation |
| Q64077209 | Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin |
| Q90664762 | Pathophysiology of ctDNA Release into the Circulation and Its Characteristics: What Is Important for Clinical Applications |
| Q30667824 | Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments |
| Q34428186 | Plasma DNA, prediction and post-traumatic complications |
| Q60046276 | Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay |
| Q81610407 | Quantification of donor-derived DNA in serum: a new approach of acute rejection diagnosis in a rat kidney transplantation model |
| Q41235268 | Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
| Q44412817 | Quantitative Analysis of Pleural Fluid Cell-free DNA as a Tool for the Classification of Pleural Effusions |
| Q34388637 | Rapid clearance of fetal DNA from maternal plasma |
| Q40449194 | Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch. |
| Q90353213 | Recent advances in heart transplantation |
| Q28601304 | Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma |
| Q33767643 | Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. |
| Q55209454 | Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing. |
| Q92111968 | The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation |
| Q55437542 | The Past, Present and Future of Heart Transplantation. |
| Q33793971 | The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts |
| Q34794715 | Universal noninvasive detection of solid organ transplant rejection |
| Q55311645 | Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract. |
Search more.